1. |
Hansell DM, Bankier AA, MacMahon H, et al. Fleischner Society: glossary of terms for thoracic imaging. Radiology, 2008, 246(3): 697-722.
|
2. |
Patel VK, Naik SK, Naidich DP, et al. A practical algorithmic approach to the diagnosis and management of solitary pulmonary nodules: part 1: radiologic characteristics and imaging modalities. Chest, 2013, 143(3): 825-839.
|
3. |
Goldstraw P, Chansky K, Crowley J, et al. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. J Thorac Oncol, 2016, 11(1): 39-51.
|
4. |
El Masri J, Ren S, Zhang J. Getting familiar with the forthcoming eighth edition of TNM classification of lung cancer: from the T to N and M descriptors. Ann Transl Med, 2016, 4(4): 67.
|
5. |
Cohen JG, Goo JM, Yoo RE, et al. Software performance in segmenting ground-glass and solid components of subsolid nodules in pulmonary adenocarcinomas. Eur Radiol, 2016, 26(12): 4465-4474.
|
6. |
Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol, 2011, 6(2): 244-285.
|
7. |
Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization Classification of Lung Tumors: Impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol, 2015, 10(9): 1243-1260.
|
8. |
Chen K, Chen H, Yang F, et al. Validation of the Eighth Edition of the TNM Staging System for Lung Cancer in 2043 surgically treated patients with non-small-cell lung cancer. Clin Lung Cancer, 2017, 18(6): e457-e466.
|
9. |
Osarogiagbon RU, Smeltzer MP, Faris N, et al. Comment on the proposals for the revision of the N descriptors in the forthcoming eighth edition of the TNM classification for lung cancer. J Thorac Oncol, 2016, 11(10): 1612-1614.
|
10. |
Tsutani Y, Miyata Y, Nakayama H, et al. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study. J Thorac Cardiovasc Surg, 2013, 146(2): 358-364.
|
11. |
Liang W, He J, Shen Y, et al. Impact of examined lymph node count on precise staging and long-term survival of resected non-small-cell lung cancer: A population study of the US SEER Database and a Chinese multi-institutional registry. J Clin Oncol, 2017, 35(11): 1162-1170.
|
12. |
Jiang L, Yin WQ, Peng GL, et al. Prognosis and status of lymph node involvement in patients with adenocarcinoma in situ and minimally invasive adenocarcinoma-a systematic literature review and pooled-data analysis. J Thorac Dis, 2015, 7(11): 2003-2009.
|
13. |
朱斌, 柳仓生. 非小细胞肺癌的淋巴结转移相关因素及规律的探讨. 中国肿瘤临床, 2012, 29(15): 1115-1118.
|
14. |
崔岳, 杨晓军, 谢天鹏, 等. 非小细胞肺癌肺内淋巴结转移规律的临床研究. 中国胸心血管外科临床杂志, 2016, 21(10): 982-987.
|
15. |
谢远财, 李运, 刘彦国, 等. 直径≤3 cm 的周围型非小细胞肺癌纵隔淋巴结转移规律的初步研究. 中国微创外科杂志, 2010, 10(7): 577-580.
|
16. |
Li H, Hu H, Wang R, et al. Lung adenocarcinoma: Are skip N2 metastases different from non-skip? J Thorac Cardiovasc Surg, 2015, 150(4): 790-795.
|